Home › NDC Lookup › RxCUI directory › RxCUI 2467148

4 ML amisulpride 2.5 MG/ML Injection — RxCUI 2467148

RxNorm drug concept · Semantic clinical drug
RxCUI 2467148 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2467148
Official name4 ML amisulpride 2.5 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asamisulpride 10 MG per 4 ML Injection; amisulpride 10 MG in 4 ML Injection; amisulpride 2.5 MG/ML per 4 ML Injection
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)49 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Amisulpride Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Barhemsys is used to prevent or treat nausea and vomiting that can happen after surgery — what doctors call postoperative nausea and vomiting, or PONV. If you're having surgery, yo...
  • Barhemsys blocks specific dopamine receptors in a part of the brain that acts like a 'nausea alarm.' When surgery and anesthesia trigger that alarm, the brain signals the body to v...
  • Most people tolerate this medicine well since it's a single, short infusion. The more commonly reported effects include chills, a temporary drop in blood pressure during the proced...
  • Yes — this is important. Barhemsys can affect the heart's electrical rhythm in a way called QT prolongation, which at higher levels can increase the risk of a serious irregular hea...
📖 Read our full Amisulpride Injection guide →

🕸️ Concept Web — How 4 ML amisulpride 2.5 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 4 ML amisulpride 2.5 MG/ML Injection RxCUI 2467148

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Amisulpride 46303
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Barhemsys 2284233
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amisulpride Injection 2284231
    • Amisulpride Injectable Product 1151984
    • Amisulpride Injection [Barhemsys] 2284235
    • Barhemsys Injectable Product 2284236
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amisulpride 2.5 MG/ML SCDC · 2284230
  • Amisulpride Injection SCDF · 2284231
  • Amisulpride Injectable Product SCDG · 1151984

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2467148 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71390-0125-20 10 CARTON in 1 PACKAGE (71390-125-20) / 1 VIAL, SINGLE-DOSE... Barhemsys Acacia Pharma Ltd 2020-02-27
71390-0125-50 10 CARTON in 1 PACKAGE (71390-125-50) / 1 VIAL, SINGLE-DOSE... Barhemsys Acacia Pharma Ltd 2020-02-27
Observed labelers: Acacia Pharma Ltd (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.